Published in J Virol Methods on January 01, 2001
Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01. Emerg Infect Dis (2002) 2.89
Rift Valley fever during rainy seasons, Madagascar, 2008 and 2009. Emerg Infect Dis (2010) 2.22
Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds. J Clin Microbiol (2001) 1.56
Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res (2012) 1.21
Rapid detection of human pathogenic orthobunyaviruses. J Clin Microbiol (2003) 1.14
Real-time reverse-transcription loop-mediated isothermal amplification for rapid detection of rift valley Fever virus. J Clin Microbiol (2008) 1.01
Use of reverse transcriptase PCR in early diagnosis of Rift Valley fever. Clin Diagn Lab Immunol (2002) 0.89
Comprehensive phylogenetic reconstructions of Rift Valley fever virus: the 2010 northern Mauritania outbreak in the Camelus dromedarius species. Vector Borne Zoonotic Dis (2014) 0.78
First External Quality Assessment of Molecular and Serological Detection of Rift Valley Fever in the Western Mediterranean Region. PLoS One (2015) 0.75
A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell (1981) 8.09
Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proc Natl Acad Sci U S A (1978) 4.17
Vectors of Chikungunya virus in Senegal: current data and transmission cycles. Am J Trop Med Hyg (1999) 3.56
Public-health impact of accelerated measles control in the WHO African Region 2000-03. Lancet (2005) 3.36
Are the 5' ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs? Cell (1979) 3.35
Transfer of 5'-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro. Proc Natl Acad Sci U S A (1979) 3.10
Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg (1995) 3.08
Stenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg (1996) 2.94
Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases. J Gen Virol (1994) 2.84
Both the 7-methyl and the 2'-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription. Proc Natl Acad Sci U S A (1980) 2.56
Genetic reassortment of Rift Valley fever virus in nature. J Virol (1999) 2.43
Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic. AIDS Res Hum Retroviruses (1993) 2.22
Rituximab in CD20 positive multiple myeloma. Leukemia (2007) 2.11
Processing of yellow fever virus polyprotein: role of cellular proteases in maturation of the structural proteins. J Virol (1989) 2.07
Epidemiological and virological influenza survey in Dakar, Senegal: 1996-1998. Am J Trop Med Hyg (2000) 1.96
Cap and internal nucleotides of reovirus mRNA primers are incorporated into influenza viral complementary RNA during transcription in vitro. J Virol (1979) 1.95
New vectors of Rift Valley fever in West Africa. Emerg Infect Dis (1998) 1.91
Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. Ann Oncol (2010) 1.91
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol (2013) 1.82
The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice. J Virol (2000) 1.79
The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules. J Virol (1995) 1.77
Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation. Virus Res (1997) 1.76
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol (2009) 1.71
Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Euro Surveill (2010) 1.69
Practical experiences in obtaining informed consent for a vaccine trial in rural Africa. N Engl J Med (1997) 1.67
Mosquito vectors of the 1998-1999 outbreak of Rift Valley Fever and other arboviruses (Bagaza, Sanar, Wesselsbron and West Nile) in Mauritania and Senegal. Med Vet Entomol (2005) 1.67
High genetic stability of the region coding for the structural proteins of yellow fever virus strain 17D. J Gen Virol (1987) 1.56
Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds. J Clin Microbiol (2001) 1.56
Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology. Leuk Res (1999) 1.55
Three-segment RNA genome of Lumbo virus (Bunyavirus). Intervirology (1973) 1.48
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials. Leukemia (2007) 1.48
Studies on lumbo virus replication. I. RNA-dependent RNA polymerase associated with virions. Virology (1976) 1.46
Soluble Fc gamma receptors. J Leukoc Biol (1993) 1.45
Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping. AIDS Res Hum Retroviruses (1996) 1.42
Rift Valley fever outbreak, Mauritania, 1998: seroepidemiologic, virologic, entomologic, and zoologic investigations. Emerg Infect Dis (2001) 1.39
[Circular ribonucleoproteins in the virus Lumbo (Bunyavirus)]. C R Acad Sci Hebd Seances Acad Sci D (1975) 1.36
Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs. J Virol (1992) 1.36
Variability of the NS(S) protein among Rift Valley fever virus isolates. J Gen Virol (1997) 1.36
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells. Ann Oncol (2008) 1.33
Seroepidemiologic, molecular, and phylogenetic analyses of simian T-cell leukemia viruses (STLV-I) from various naturally infected monkey species from central and western Africa. Virology (1994) 1.28
Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE/IBE/WHO study. Seizure (2005) 1.28
Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer (1995) 1.25
Stable secondary structures at the 3'-end of the genome of yellow fever virus (17 D vaccine strain). FEBS Lett (1985) 1.24
Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. J Virol (2009) 1.24
Origin of 1997-98 Rift Valley fever outbreak in East Africa. Lancet (1998) 1.24
Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells. J Virol (2012) 1.23
Prognostic utility of intact immunoglobulin Ig'κ/Ig'λ ratios in multiple myeloma patients. Leukemia (2012) 1.23
Acquisition bias may have led to acceptance of the false null hypothesis that prevalence of scoliosis is the same in cystic fibrosis as the general population. Pediatr Pulmonol (2013) 1.20
Analysis of the 3' terminal sequence recognized by the Rift Valley fever virus transcription complex in its ambisense S segment. Virology (1997) 1.19
Highly sensitive Taqman PCR detection of Puumala hantavirus. Microbes Infect (2001) 1.14
[Prevention of transfusion transmitted malaria in endemic area]. Transfus Clin Biol (2009) 1.13
Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients. Br J Cancer (1994) 1.12
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. Infect Immun (2001) 1.10
The Rift Valley fever virus nonstructural protein NSs is phosphorylated at serine residues located in casein kinase II consensus motifs in the carboxy-terminus. Virology (1999) 1.09
Sequence and phylogenetic analyses of a new STLV-I from a naturally infected tantalus monkey from Central Africa. Virology (1993) 1.09
A case of cervical Pott's disease revealed by parapharyngeal abscess. Eur Ann Otorhinolaryngol Head Neck Dis (2011) 1.08
First isolation of the Rift Valley fever virus from Culex poicilipes (Diptera: Culicidae) in nature. Am J Trop Med Hyg (2000) 1.07
Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth (2006) 1.06
Evaluation of a Crimean-Congo hemorrhagic fever virus recombinant antigen expressed by Semliki Forest suicide virus for IgM and IgG antibody detection in human and animal sera collected in Iran. J Clin Virol (2005) 1.05
Resistance to Rift Valley fever virus in Rattus norvegicus: genetic variability within certain 'inbred' strains. J Gen Virol (2000) 1.03
Emergence of subtype Zaire Ebola virus in Gabon. Virology (1997) 1.01
First evidence of natural vertical transmission of yellow fever virus in Aedes aegypti, its epidemic vector. Trans R Soc Trop Med Hyg (1998) 1.01
HCV infection in a rural population of the Central African Republic (CAR): evidence for three additional subtypes of genotype 4. J Med Virol (1995) 1.01
Idiopathic sclerosing encapsulating peritonitis: a case in an adolescent girl. Diagn Interv Imaging (2012) 1.01
Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons. Leukemia (2002) 1.01
Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections. J Gen Virol (1998) 1.01
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience. Leukemia (2011) 0.99
The S segment of the Germiston virus RNA genome can code for three proteins. Virus Res (1987) 0.99
[Phlebotomus of Senegal: survey of the fauna in the region of Kedougou. Isolation of arbovirus]. Bull Soc Pathol Exot (1999) 0.98
Molecular epidemiology and emergence of Rift Valley fever. Mem Inst Oswaldo Cruz (1999) 0.98
A transcript from the S segment of the Germiston bunyavirus is uncapped and codes for the nucleoprotein and a nonstructural protein. J Virol (1984) 0.98
Persistent infection of mammalian cells by Rift Valley fever virus. J Gen Virol (1996) 0.98
Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study. J Clin Oncol (1996) 0.97
Studies on Lumbo virus replication. II. Properties or viral ribonucleoproteins and characterization of messenger RNAs. Virology (1976) 0.97
[Rift valley fever and Zinga virus: a pathogenic arbovirus in man and animal new for Madagascar]. Arch Inst Pasteur Madagascar (1984) 0.96
[Ngari virus (Bunyaviridae: Bunyavirus). First isolation from humans in Senegal, new mosquito vectors, its epidemiology]. Bull Soc Pathol Exot (1996) 0.96
[Resurgence of yaws in Central African Republic. Role of the Pygmy population as a reservoir of the virus]. Bull Soc Pathol Exot (1992) 0.96
Activity of Toscana and Rift Valley fever virus transcription complexes on heterologous templates. J Gen Virol (2001) 0.95
International network for capacity building for the control of emerging viral vector-borne zoonotic diseases: ARBO-ZOONET. Euro Surveill (2009) 0.95
Modulations of the in vitro translational efficiencies of Yellow Fever virus mRNAs: interactions between coding and noncoding regions. Nucleic Acids Res (1989) 0.95
[Role of Toscana virus in meningo-encephalitis in Tunisia]. Pathol Biol (Paris) (2010) 0.95
Increase of HIV-1 subtype A in Central African Republic. J Acquir Immune Defic Syndr (1999) 0.95
Expression of the nucleoprotein of the Puumala virus from the recombinant Semliki Forest virus replicon: characterization and use as a potential diagnostic tool. Clin Diagn Lab Immunol (2003) 0.94
[RNA polymerase activity associated with a bunya virus (Lumbo)]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.94
[Demonstration of circular ribonucleic acid in the Lumbo virus (Bunyavirus)]. C R Acad Sci Hebd Seances Acad Sci D (1976) 0.93
Re-emergence of yellow fever in Senegal in 1995. Am J Trop Med Hyg (1998) 0.93
Infections by viruses of the families Bunyaviridae and Filoviridae. Rev Sci Tech (2000) 0.93
Human water contacts patterns in Schistosoma mansoni epidemic foci in northern Senegal change according to age, sex and place of residence, but are not related to intensity of infection. Trop Med Int Health (2003) 0.93
Identification of the Ebola virus in Gabon in 1994. Lancet (1997) 0.92
Characterization of yellow fever virus proteins E and NS1 expressed in Vero and Spodoptera frugiperda cells. J Gen Virol (1991) 0.92
Panhandles and hairpin structures at the termini of germiston virus RNAs (Bunyavirus). Virology (1982) 0.92
[Effect of actinomycin D on the replication of Tahyna virus]. Ann Microbiol (Paris) (1973) 0.91
[Rift Valley fever: sporadic infection of French military personnel outside currently recognized epidemic zones]. Med Trop (Mars) (2002) 0.91
Nucleotide sequence of the M segment of Germiston virus: comparison of the M gene product of several bunyaviruses. Virus Res (1988) 0.91
Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions. Immunol Lett (1999) 0.91